• KOLs
  • Dna Ploidy
  • Billie‐jo M Kerns

Billie‐Jo M Kerns: Influence Statistics

Billie‐Jo M Kerns

Billie‐Jo M Kerns

BioGenex, San Jose, California | Cell Imaging Laboratory, Duke University Medical Center, Durham, North Carolina | BioGenex, San Ramon, California | Becton Dickinson‐Cellular ...

Billie‐Jo M Kerns: Expert Impact

Concepts for which Billie‐Jo M Kerns has direct influence: Dna ploidy , Image analysis , Breast cancer , Acne keloidalis , Dna content , Image cytometry , Ovarian cancers .

Billie‐Jo M Kerns: KOL impact

Concepts related to the work of other authors for which for which Billie‐Jo M Kerns has influence: Ovarian cancer , P53 protein , Her2 neu , Situ hybridization , Prognostic significance , Breast carcinoma , Cell lines .

KOL Resume for Billie‐Jo M Kerns

Year
1997

BioGenex, San Jose, California

Cell Imaging Laboratory, Duke University Medical Center, Durham, North Carolina

1996

Becton Dickinson‐Cellular Imaging Systems, San Jose, California

Departments of Pathology and Surgery (Urology), Duke University Medical Center, Durham, North Carolina

University of Texas, M. D. Anderson Cancer Center, Houston, Texas

1995

Department of Pathology, Duke University Medical Center, Durham, North Carolina

1994

Departments of Pathology, Duke University Medical Center, Durham, North Carolina

1993

Department of Surgery, Duke University Medical Center, Durham, North Carolina.

1992

Division of Urology, Duke University Medical Center, Durham, NC 27710, USA

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.

1991

From the Departments of Surgery, Pathology, and the Duke Breast Oncology Clinic, Duke University Medical Center, Durham, North Carolina

Read before the 44th Annual Meeting of the Society of Surgical Oncology, Orlando, FL

1990

From the Department of Pathology (A.J.H., B.J.K.) and the Division of Dermatology (S.M.D., S.V.P.), Duke University Medical Center, Durham, North Carolina.

1989

Arlene J. Herzberg, M.D., Resident, and B.J. Kearns, Medical Technologist, Department of Pathology; and Sheldon V. Pollack, M.D., Associate Professor of Medicine, Division of Dermatology, are from Duke University School of Medicine, Durham, North Carolina.

Prominent publications by Billie‐Jo M Kerns

KOL-Index: 11562 . OBJECTIVE: Overexpression of the p53 and HER-2/neu oncogenes are the two most common genetic abnormalities associated with breast cancer. Shorter survival time has been reported in patients with tumors with p53 or HER-2/neu. This report analyzes a retrospective cohort of early stage breast cancers for both oncogenes and relates overexpression to clinicopathologic parameters and ...
Known for Her2 Neu | Stage Breast | Overexpression P53 | Positive Staining
KOL-Index: 11446 . BACKGROUND: Several molecular-genetic alterations in endometrial cancers, including aneuploidy and aberrant expression of p53 and HER-2/neu, have been associated with poor prognosis. To determine the importance of molecular-genetic factors relative to more traditional surgical-pathologic prognostic factors, a multivariable analysis was performed. METHODS: Immunohistochemical staining for ...
Known for Dna Ploidy | Multivariable Analysis | Estrogen Receptors | Her2 Neu
KOL-Index: 10927 . To investigate epidermal growth factor receptor (EGFr) presence in the prostate, monoclonal antibody (clone EGFR1) immunohistochemical examination of radical prostatectomy specimens was performed (n = 37). All prostatic specimens contained benign prostatic hyperplasia (BPH) and/or dysplasia (prostatic intraepithelial neoplasia or PIN), as well as prostatic carcinoma (CaP). Areas of ...
Known for Pin Cap | Basal Cells | Egfr Immunoreactivity | Prostatic Tissues
KOL-Index: 9949 . BACKGROUND: Tumors of borderline malignancy are still a controversial subgroup of ovarian neoplasms. The expression of several cell regulatory proteins was studied to characterize the molecular phenotype of these tumors, and to compare them with their benign and malignant counterparts. METHODS: Specimens from 22 patients with tumors of borderline malignancy (11 serous and 11 mucinous ...
Known for Borderline Tumors | Egfr Expression | Her2 Neu | Ovarian Neoplasms
KOL-Index: 9695 . DNA ploidy has been shown to have prognostic value in adenocarcinoma of the prostate. While occasional benign lesions of the prostate may be associated with a DNA aneuploid status, most aneuploid epithelial proliferations of the prostate are carcinomas. Because of the relationship between aneuploidy and malignancy, DNA ploidy analysis might improve detection of adenocarcinoma in small ...
Known for Dna Ploidy | Core Biopsy | Diagnosis Malignancy | Adenocarcinoma Prostate
KOL-Index: 8561 . The quantitation of estrogen and progesterone receptors (ER and PgR) has become the standard of care in the evaluation of patients with primary breast carcinoma. It has been demonstrated that ER and PgR detected by immunohistochemical methods in formalin-fixed paraffin-embedded tissue can be quantified by computerized image analysis. In this study, ER and PgR levels were determined by ...
Known for Breast Carcinoma | Estrogen Receptors | Dcc Method | Progesterone Receptor
KOL-Index: 7961 . OBJECTIVE: To determine the utility of measuring the tumor proliferation index as a prognostic marker in patients with non-small-cell lung cancer. DESIGN: Immunostaining for the proliferation-associated antigen Ki-67, quantitated using computer-assisted image cytometry, was used to derive the tumor proliferation index for 61 fresh-frozen, banked specimens of non-small-cell lung cancer. DNA ...
Known for Cell Lung | Prognostic Significance | Tumor Proliferation | Dna Content
KOL-Index: 7070 . OBJECTIVE: Our purpose was to determine whether protein tyrosine phosphatase 1B is overexpressed in ovarian cancers, possibly altering the balance of intracellular tyrosine phosphorylation. STUDY DESIGN: The expression of protein tyrosine phosphatase 1B was assayed in frozen sections from 54 human ovarian carcinomas and seven normal ovaries by immunochemical staining with monoclonal ...
Known for Tyrosine Phosphatase | Ovarian Cancers | Expression Protein | Tumor Cells

Key People For Dna Ploidy

Top KOLs in the world
#1
David William Hedley
pancreatic cancer flow cytometry tumor hypoxia
#2
Ian W Taylor
cellular dna content flow cytometry cell cycle
#3
Michael Leonard Friedlander
ovarian cancer maintenance olaparib brca1 genes
#4
Elizabeth A Musgrove
breast cancer cyclin d1 cell cycle
#5
Catherine A Rugg
transferrin receptor expression cellular dna content flow cytometry
#6
Bernhard Tribukait
cell cycle flow cytometry ulcerative colitis

BioGenex, San Jose, California | Cell Imaging Laboratory, Duke University Medical Center, Durham, North Carolina | BioGenex, San Ramon, California | Becton Dickinson‐Cellular Imaging Systems, San Jose, California | Becton Dickinson Cellular Imaging S